The epidemiology, treatment, and prevention of transmission of methicillin-resistant staphylococcus aureus

Journal of Infusion Nursing

Volumn 34, Issue 6, 2011, Pages 359-364

  Calfee, David P ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAROLINE; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; LINEZOLID; METICILLIN; RIFAMPICIN; TETRACYCLINE DERIVATIVE; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; DISEASE TRANSMISSION; DISINFECTION; DRUG EFFICACY; ENVIRONMENTAL SANITATION; HAND WASHING; HEALTH EDUCATION; HUMAN; HYGIENE; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SKIN INFECTION; SOFT TISSUE INFECTION;

COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; HUMANS; INFUSIONS, INTRAVENOUS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; UNITED STATES;

EID: 82155181679     PISSN: 15331458     EISSN: 15390667     Source Type: Journal    
DOI: 10.1097/NAN.0b013e31823061d6     Document Type: Article

References (50)

1. Hidron A, Edwards J, Patel J, et al. NHSN annual update: antimicrobial- resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008;29:996-1011.
2. Barber M. Methicillin-resistant staphylococci. J Clin Pathol. 1961;14:385-393.
3. Barrett F, McGehee R, Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital. N Engl J Med. 1968;279:441-448.
4. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med. 2001;344(1):11-16. (Pubitemid 32064839)
5. Wertheim HF, Vos MC, Ott A, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet. 2004;364(9435):703-705. (Pubitemid 39140626)
6. Keene A, Vavagiakis P, Lee MH, et al. Staphylococcus aureus colonization and the risk of infection in critically ill patients. Infect Control Hosp Epidemiol. 2005;26(7):622-628. (Pubitemid 41073402)
7. Lautenbach E, Nachamkin I, Hu B, et al. Surveillance cultures for detection of methicillin-resistant Staphylococcus aureus: diagnostic yield of anatomic sites and comparison of provider- and patient-collected samples. Infect Control Hosp Epidemiol. 2009;30(4):380-382.
8. Mody L, Kauffman CA, Donabedian S, Zervos M, Bradley SF. Epidemiology of Staphylococcus aureus colonization in nursing home residents. Clin Infect Dis. 2008;46(9):1368-1373. (Pubitemid 351589935)
9. Shurland SM, Stine OC, Venezia RA, et al. Colonization sites of USA300 methicillin-resistant Staphylococcus aureus in residents of extended care facilities. Infect Control Hosp Epidemiol. 2009;30(4):313-318.
10. Yang ES, Tan J, Eells S, Rieg G, Tagudar G, Miller LG. Body site colonization in patients with community-associated methicillinresistant Staphylococcus aureus and other types of S aureus skin infections. Clin Microbiol Infect. 2010;16(5):425-431.
11. Salgado C, Farr B. What proportion of hospital patients colonized with methicillin-resistant Staphylococcus aureus are identified by clinical microbiological cultures? Infect Control Hosp Epidemiol. 2006;27:116-121. (Pubitemid 43384756)
12. Feng PJ, Kallen AJ, Ellingson K, Muder R, Jain R, Jernigan JA. Clinical incidence of methicillin-resistant Staphylococcus aureus (MRSA) colonization or infection as a proxy measure for MRSA transmission in acute care hospitals. Infect Control Hosp Epidemiol. 2011;32(1):20-25.
13. Jarvis W, Schlosser J, Chinn R, Tweeten S, Jackson M. National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US health care facilities, 2006. Am J Infect Control. 2007;35:631-637. (Pubitemid 350184164)
14. Johnson L, Jose J, Yousif F, Pawlak J, Saravolatz L. Prevalence of colonization with community-associated methicillin-resistant Staphylococcus aureus among end-stage renal disease patients and healthcare workers. Infect Control Hosp Epidemiol. 2009;30(1):4-8.
15. MacKinnon M, Allen K. Long-term MRSA carriage in hospital patients. J Hosp Infect. 2000;46(3):216-221.
16. Scanvic A, Denic L, Gaillon S, Giry P, Andremont A, Lucet J. Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clin Infect Dis. 2001;32(10):1393-1398. (Pubitemid 32424271)
17. Sanford M, Widmer A, Bale M, Jones R, Wenzel R. Efficient detection and long-term persistence of the carriage of methicillinresistant Staphylococcus aureus. Clin Infect Dis. 1994;19(6): 1123-1128. (Pubitemid 24380028)
18. Huang S, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis. 2003;36:281-285. (Pubitemid 36169662)
19. Freitas E, Harris R, Blake R, Salgado C. Prevalence of USA300 strain type of methicillin-resistant Staphylococcus aureus among patients with nasal colonization identified with active surveillance. Infect Control Hosp Epidemiol. 2010;31:469-475.
20. Pacio G, Visintainer P, Maguire G, Wormser G, Raffalli J, Montecalvo M. Natural history of colonization with vancomycinresistant enterococci, methicillin-resistant Staphylococcus aureus, and resistant gram-negative bacilli among long-term-care facility residents. Infect Control Hosp Epidemiol. 2003;24:246-250. (Pubitemid 36538135)
21. Bradley SF. Methicillin-resistant Staphylococcus aureus: longterm care concerns. Am J Med. 1999;106(5A):2S-10S; discussion 48S-52S. (Pubitemid 29239276)
22. Johnson PD, Martin R, Burrell LJ, et al. Efficacy of an alcohol/chlorhexidine hand hygiene program in a hospital with high rates of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection. Med J Aust. 2005;183(10):509-514. (Pubitemid 41723325)
23. Hardy KJ, Oppenheim BA, Gossain S, Gao F, Hawkey PM. A study of the relationship between environmental contamination with methicillin-resistant Staphylococcus aureus (MRSA) and patients acquisition of MRSA. Infect Control Hosp Epidemiol. 2006;27(2):127-132. (Pubitemid 43384758)
24. Sexton T, Clarke P, ONeill E, Dillane T, Humphreys H. Environmental reservoirs of methicillin-resistant Staphylococcus aureus in isolation rooms: correlation with patient isolates and implications for hospital hygiene. J Hosp Infect. 2006;62(2): 187-194. (Pubitemid 43056660)
25. Tacconelli E, De Angelis G, Cataldo MA, Pozzi E, Cauda R. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother. 2008;61(1):26-38.
26. Bloemendaal AL, Fluit AC, Jansen WM, et al. Acquisition and cross-transmission of Staphylococcus aureus in European intensive care units. Infect Control Hosp Epidemiol. 2009;30(2): 117-124.
27. Borg MA, Suda D, Scicluna E. Time-series analysis of the impact of bed occupancy rates on the incidence of methicillin-resistant Staphylococcus aureus infection in overcrowded general wards. Infect Control Hosp Epidemiol. 2008;29(6):496-502. (Pubitemid 351918027)
28. Herold B, Immergluck L, Maranan M, et al. Communityacquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998;279(8): 593-598. (Pubitemid 28110205)
29. Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rpt. 1999;48(32):707-709.
30. Li M, Diep BA, Villaruz AE, et al. Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A. 2009;106(14):5883-5888.
31. Moran G, Krishnadasan A, Gorwitz R, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666-674.
32. Klevens R, Morrison M, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298:1763-1771. (Pubitemid 47598444)
33. Ellis M, Hospenthal D, Dooley D, Gray P, Murray C. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis. 2004;39:971-979. (Pubitemid 39313452)
34. Gorwitz RJ, Kruszon-Moran D, McAllister SK, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis. 2008;197(9):1226-1234. (Pubitemid 351632753)
35. Creech CB, Kernodle DS, Alsentzer A, Wilson C, Edwards KM. Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J. 2005;24(7):617-621. (Pubitemid 40993616)
36. Lautenbach E, Tolomeo P, Nachamkin I, Hu B, Zaoutis T. The impact of household transmission on duration of outpatient colonization with methicillin-resistant Staphylococcus aureus. Epidemiol Infect. 2010;138:683-685.
37. Fritz S, Epplin E, Garbutt J, Storch G. Skin infection in children colonized with community-associated methicillin-resistant Staphylococcus aureus. J Infect. 2009;59:394-401.
38. Szumowski J, Wener K, Gold H, et al. Methicillin-resistant Staphylococcus aureus colonization, behavioral risk factors, and skin and soft-tissue infection at an ambulatory clinic serving a large population of HIV-infected men who have sex with men. Clin Infect Dis. 2009;49(1):118-121.
39. Maree C, Daum R, Boyle-Vavra S, Matayoshi K, Miller L. Community-associated methicillin-resistant Staphylococcus aureus isolates and healthcare-associated infections. Emerg Infect Dis. 2007;13:236-242. (Pubitemid 46193166)
40. Popovich KJ, Weinstein RA, Hota B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis. 2008;46(6):787-794. (Pubitemid 351417176)
41. Jenkins TC, McCollister BD, Sharma R, et al. Epidemiology of healthcare-associated bloodstream infection caused by USA300 strains of methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Infect Control Hosp Epidemiol. 2009;30(3):233-241.
42. Diep B, Chambers H, Graber C, et al. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med. 2008;148:249-257. (Pubitemid 351665484)
43. Rajendran PM, Young D, Maurer T, et al. Randomized, doubleblind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community- acquired methicillin-resistant Staphylococcus aureus infection. Antimicrob Agents Chemother. 2007;51(11):4044-4048. (Pubitemid 350057804)
44. Lee MC, Rios AM, Aten MF, et al. Management and outcome of children with skin and soft tissue abscesses caused by communityacquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J. 2004;23(2):123-127. (Pubitemid 38222783)
45. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin- resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18-55.
46. Calfee DP, Salgado CD, Classen D, et al. Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol. 2008; 29(suppl 1):S62-S80.
47. Siegel J, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in healthcare settings, 2006. Centers for Disease Control and Prevention. http://www.cdc.gov/ ncidod/dhqp/pdf/ar/ MDROGuideline2006.pdf. Accessed July 16, 2010.
48. Smith P, Bennett G, Bradley S, et al. SHEA/APIC guideline: infection prevention and control in the long-term care facility. Infect Control Hosp Epidemiol. 2008;29(9):785-814.
49. Climo MW, Sepkowitz KA, Zuccotti G, et al. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasiexperimental multicenter trial. Crit Care Med. 2009;37(6):1858-1865.
50. Evans H, Dellit T, Chan J, Nathens A, Maier R, Cuschieri J. Effect of chlorhexidine whole-body bathing on hospital-acquired infections among trauma patients. Arch Surg. 2010;145(3): 240-246.